CASTLE BIOSCIENCES, INC. Contract Liability (Deferred Revenue)
CASTLE BIOSCIENCES, INC. (CSTL) had Contract Liability (Deferred Revenue) of $0 as of 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2022-02-28
- 2021-12-31: Contract with Customer, Liability, Current $0.00.
- 2021-09-30: Contract with Customer, Liability, Current $3.00M.
- 2021-06-30: Contract with Customer, Liability, Current $6.18M.
- 2021-03-31: Contract with Customer, Liability, Current $8.18M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-28 |
| 2021-09-30 | $3.00M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $6.18M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $8.18M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $6.62M 10-K · filed 2022-02-28 |
| 2020-09-30 | $8.35M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $8.35M 10-Q · filed 2020-08-10 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |